Child–Pugh Score and ABCG2-rs2231142 Genotype Independently Predict Survival in Advanced Hepatoma Patients Treated with Sorafenib

Patients with advanced hepatocellular carcinoma (HCC) are treated by immunotherapy and/or targeted agents, such as sorafenib. Several single nucleotide polymorphisms (SNPs) and clinical scores have been proposed as prognostic markers in HCC patients treated with sorafenib. This study aimed to valida...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Po-Han, Yu, Jen, Chu, Yin-Yi, Lin, Yang-Hsiang, Yeh, Chau-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105641/
https://www.ncbi.nlm.nih.gov/pubmed/35566676
http://dx.doi.org/10.3390/jcm11092550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105641/
https://www.ncbi.nlm.nih.gov/pubmed/35566676
http://dx.doi.org/10.3390/jcm11092550

Ejemplares similares